Brought to you by 
Altus Pharmaceuticals completes $97.7mm IPO
31 Jan 2006
Executive Summary
After filing for a $115mm IPO in October 2005, Altus Pharmaceuticals (developing therapeutics for metabolic and gastrointestinal disorders) has finally sold 7mm common shares priced at $15 each, netting $97.7mm for the company.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Altus Pharmaceuticals completes $97.7mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice